12931_2021_1714_MOESM1_ESM.docx (38.8 kB)
Download file

Additional file 1 of Comparative outcomes in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis

Download (38.8 kB)
journal contribution
posted on 2021-05-05, 03:40 authored by Manon Belhassen, Faustine Dalon, Maëva Nolin, Eric Van Ganse
Additional file 1: Table S1. ICD-10 codes for exclusion criteria. Table S2. ICD-10 codes for acute respiratory-related hospitalisations (main diagnosis). Table S3. Unadjusted incidence rates and cumulative incidence of mortality in patients newly treated in 2016 with antifibrotic drugs. Figure S1. Comparison of overall mortality in patients newly treated in 2016 with pirfenidone or nintedanib.

Funding

F. Hoffmann-La Roche

History